Thank you to all who joined us live for PrimaryCareNOW on Friday–Saturday, May 14–15. If you were not able to join us, some sessions have been recorded and are available below.
Upcoming Virtual Conferences
Agenda
CME/CE Accredited Session
Non-CME/CE Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
8–9am ET CME/CE Accredited Session
Alcohol in the Anxious Age of COVID: Medications Against Self-Medications
Petros Levounis, MD, MA
Alcohol use frequently co-occurs with anxiety disorders, especially during the highly anxiety-provoking circumstances of the current pandemic. People increasingly self-medicate their stress with alcohol, sometimes leading to frank alcohol use disorder. Despite alcohol’s legal status and social acceptability in many countries, it remains a potentially dangerous, toxic substance. Withdrawal from alcohol can be fatal, and medically managed withdrawal is often necessary to ensure patient safety. In this presentation, we will describe the fundamental pharmacology and acute presentations of alcohol use disorder and discuss counseling approaches. We will then explore the clinical aspects of the three FDA-approved medications for its treatment: disulfiram, naltrexone, and acamprosate. We will conclude with some novel ideas about future directions in the pharmacotherapy of alcohol use disorders.
Petros Levounis, MD, MA
Professor and Chair, Department of Psychiatry, Rutgers New Jersey Medical School, Chief of Service, University Hospital, Newark, NJ
9:10–10:10am ET CME/CE Accredited Session
Managing Obesity in Primary Care Practice
Fatima Cody Stanford, MD, MPH, MPA, FAAP, FACP, FTOS
Obesity is the most prevalent chronic disease of the modern era in the U.S. and around the world, affecting both the adult and pediatric population. Although many believe that helping patients to achieve a healthy weight is of minimal complexity, weight regulation and management is a challenging endeavor. In this talk, the faculty will explore the complexities of obesity and offer a range of strategies (behavioral, therapeutic, and surgical) to help you in the quest to address overweight and obesity in your practice.
Fatima Cody Stanford, MD, MPH, MPA, FAAP, FACP, FTOS
Obesity Medicine Physician Scientist, Massachusetts General Hospital and Harvard Medical School, Boston, MA
10:20–11:05am ET Non-CME Industry Theater
The Interconnected Cardio-Renal-Metabolic (CRM) Systems
Eugene E Wright Jr., MD | Kris Vijay, MD, MS, FACP, FACC, FNLA, FCRS, FHFSA
The objectives of the program are to:
- Review the interconnected nature of the CRM systems
- Identify the shared risk factors that contribute to the development and progression of clinically comorbid conditions within these systems
- Discuss the impact of coexisting conditions of the CRM systems and the continuum of risk
- Highlight a collaborative care approach for patients who are at risk for or have established disorders of the CRM systems
Eugene E Wright Jr., MD
Consulting Associate, Department of Medicine, Duke University Medical Center, Medical Director Performance Improvement, Charlotte Area Health Education Center (AHEC)
Kris Vijay, MD, MS, FACP, FACC, FNLA, FCRS, FHFSA
Medical Director, CHF, Abrazo Arizona Heart Hospital and Abrazo Health Network, Clinical Professor of Medicine, University of Arizona, Adjunct Professor of Medicine, Midwestern University, Glendale, Arizona, Associate Editor, Journal of Clinical Lipidology, Past Governor, ACC Arizona, Founding Member and Past President, Cardiorenal Society of America (CRSA), Founding member and President, Twinepidemic, Inc, President, Innovative Cardiometabolic Center
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
10:20–11:05am ET Non-CME Industry Theater
Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain
Paul G. Sutej, MD
- Understand the causes and prevalence of chronic low back pain
- Differentiate inflammatory back pain (IBP) from mechanical back pain
- Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS)
- Learn the importance of referring patients with IBP to a rheumatologist in a timely manner
Paul G. Sutej, MD
Sponsored by AbbVie
11:15am–12:15pm ET CME/CE Accredited Session
Top Questions I Get Asked About…Glaucoma, Hypertension, and Asthma
Yvonne I. Chu, MD, MBA | Karol E. Watson, MD, PhD | Sunjay R. Devarajan, MD
What do primary care providers need to know about glaucoma, hypertension, and asthma? Join ophthalmologist Yvonne Chu, cardiologist Karol Watson, and pulmonologist Sunjay Devarajan as they review important questions they get asked about these topics!
Yvonne I. Chu, MD, MBA
Associate Professor, Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX
Karol E. Watson, MD, PhD
Professor of Medicine/Cardiology, David Geffen School of Medicine at UCLA, Co-director, UCLA Program in Preventive Cardiology, David Geffen School of Medicine at UCLA, Director, UCLA Barbra Streisand Women's Heart Health Program, David Geffen School of Medicine at UCLA, Los Angeles, CA
Sunjay R. Devarajan, MD
Assistant Professor, Division of Pulmonary & Critical Care, Baylor College of Medicine, Houston, TX
12:25–1:25pm ET CME/CE Accredited Session
"My Belly Hurts and I'm Having Bowel Problems": Stepping Up Treatment of Irritable Bowel Syndrome and Chronic Idiopathic Constipation
Philip Schoenfeld, MD, MSEd, MSc
This activity will provide an evidence-based approach to the diagnosis and management of irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.
Philip Schoenfeld, MD, MSEd, MSc
Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI
Supported by Allergan and Ironwood Pharmaceuticals, Inc. Salix Pharmaceuticals
1:35–2:20pm ET Non-CME Industry Theater
Victor Howard, MD, FACC
- Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA).
- Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population
- Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial
Victor Howard, MD, FACC
Senior Medical Director, Cardiovascular US Medical Affairs, AstraZeneca
Dr. Howard was born in Charleston, West Virginia and is the second eldest of five siblings. His family moved to Texas at an early age, but ultimately all transitioned to Florida. He received his Bachelor of Science undergraduate degree and medical degree from the University of Miami with AΩA honors. He completed his residency in Internal Medicine at Parkland Hospital/University of Texas Southwestern Medical School in Dallas, Texas. He completed his fellowship in cardiology at the Methodist Hospital/Texas Medical Ctr. Baylor College of Medicine in Houston, Texas.
He returned to Florida to practice general and interventional cardiology on the southwest coast of Florida for over 28 years. After a few years in a multispecialty practice he transitioned to building the largest single specialty practice in the state of Florida based in Sarasota. During that time he developed a highly regarded cardiology practice, but also was extensively involved in education, external consultation, and participation in over 60 clinical research trials. In March, 2014 he transitioned to a field medical directorship in the cardiovascular division of medical affairs at Astra Zeneca. His primary responsibility is to provide scientific and clinical expertise with respect to brand medical strategy as well as to develop enhanced peer relationships with physicians and institutions in the cardiovascular arena. His involvement extends to areas such as investigator sponsored research, support of clinical trials and major conferences/advisory boards and education., , He resides in Sarasota, Florida with his wife Tiffany and three children Nathan, Nick, and Sophia. He enjoys the symphony, opera, and theater as well as spending time with his family whether it be relaxing on the beach or hiking and skiing in the mountains.
Sponsored by AstraZeneca Pharmaceuticals, LP
1:35–2:20pm ET Non-CME Industry Theater
Close to the Heart: The Importance of Recognizing Cardiovascular Risk in Type 2 Diabetes
Carlos Campos, MD, MPH, CDE
The objective of this program is to communicate the importance of addressing cardiovascular risk in patients with type 2 diabetes. The program will cover data on prevalence, morbidity, mortality, and intensive versus conventional glucose lowering on macrovascular complications. In addition, the program will review guidance from leading medical associations that is based upon completed cardiovascular outcome trials of antihyperglycemic medications in patients with type 2 diabetes.
Carlos Campos, MD, MPH, CDE
Clinical Adjunct Professor, UT Health San Antonio, San Antonio, TX
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
2:30–3:30pm ET CME/CE Accredited Session
Know the Facts and Save a Life: Detection and Management of Intracranial Aneurysm in Primary Care
Christopher S. Ogilvy, MD
One in fifty people in the U.S. has an unruptured brain aneurysm, and one ruptures every 18 minutes. Despite low frequency, brain aneurysms are high in mortality, because the lack of a timely diagnosis often leads to death. Complicating matters more, many of the symptoms are associated with other less dangerous conditions, such as influenza or stress. This session will describe the importance of early detection, since brain aneurysms are treatable via proper identification, and will highlight risk factors and populations who are most vulnerable. Faculty will also review treatment options for clinicians to recognize or use in practice.
Christopher S. Ogilvy, MD
Director, Endovascular and Operative Neurovascular Surgery, BIDMC Brain Aneurysm Institute, Professor of Neurosurgery, Harvard Medical School, Boston, MA
Supported by N/A
3:40–4:25pm ET Non-CME Industry Theater
Exacerbations of COPD: Consequences and Considerations
Neil Skolnik, MD
Uncovering the burden of COPD exacerbations may help in generating an appreciation of the range of associated consequences to the patient. This program will define exacerbation severity in COPD, review the possible impact of both moderate and severe COPD exacerbations, and highlight important considerations for appropriate COPD management.
Neil Skolnik, MD
Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health
Sponsored by AstraZeneca
3:40–4:25pm ET Non-CME Industry Theater
A Treatment Options for Adult Patients with Insomnia
Michael Ledet, MD
In a presentation with Dr. Ledet, learn about the pivotal clinical data and a pilot study that evaluated the next-dose transition from a treatment to this treatment option.
Michael Ledet, MD
Medical Director, Southeast Regional Center for Sleep/Wake Disorders at Springhill Medical Center
Dr. Ledet has been the Medical Director of Southeast Regional Center for Sleep/Wake Disorders at Springhill Medical Center for the past 30 years in Mobile, Alabama and is board certified in Family Medicine, Sleep Medicine, and Lipidology.
Sponsored by Eisai Inc.
8–9am ET CME/CE Accredited Session
End of Life Care Planning: Considerations in The Time of COVID-19
Lee A. Lindquist, MD, MPH, MBA
With the COVID-19 pandemic, older adults have experienced severe illness, increased hospitalizations, and mortality at alarming rates. Nursing homes and long-term care retirement communities emerged as COVID-19 hotspots with rampant outbreaks. Every older adult diagnosed with or exposed to COVID-19 has realized the potential ramifications. Providers have been at the forefront of mediating these decisions. Dr. Lindquist will discuss how long-term care and end of life planning have been impacted by COVID-19. Utilizing real-world examples with older adults and experiences in home-based and nursing home care, Dr. Lindquist will showcase how to prepare older adults and their loved ones for the consequences of COVID-19.
Lee A. Lindquist, MD, MPH, MBA
Chief of Geratrics, Northwestern University Feinberg School of Medicine, Chicago, IL
9:10–10:10am ET CME/CE Accredited Session
Evaluation and Treatment of Hip, Knee, and Back Pain in the Outpatient Setting
Stephen N. Henry, DO, MS
Hip, knee, and back pain are common complaints in the outpatient setting. It is critical for primary care providers to develop an evidence-based systematic approach to address these complaints. This presentation will improve familiarity with anatomy of the hip, knee, and back through a case-based approach. Learners will be able to generate differential diagnoses for pain in the aforementioned regions and determine appropriate imaging studies using ACR Appropriateness Criteria. The learner will be able to identify cases that require subspecialty care.
Stephen N. Henry, DO, MS
Team Physician University of Miami Intercollegiate Athletics, Team Physician Miami Marlins, Primary Care Sports Medicine Attending Physician, Uhealth Jackson Urgent Care Attending Physician, University of Miami Miller School of Medicine, Miami, FL
10:20–11:05am ET Non-CME Industry Theater
Case Study: A 51-Year-Old Female With Crohn’s Disease and Intestinal Resection
Ann Michalek, MD
*This is a hypothetical case and not an actual patient
Uncover the cause of the patient's symptoms in this virtual case study and consider if this could apply to any patients you manage.
Ann Michalek, MD
Associate Professor of Clinical Medicine, Albany Medical Center, Delmar, NY
Sponsored by Takeda Pharmaceuticals U.S.A., Inc.
10:20–11:05am ET Non-CME Industry Theater
Early Recognition of axSpA in Primary Care Chapter 5: Importance of Screenings Tools for Referrals
Marina N. Magrey, MD | Abhijeet S. Danve, MBBS, MD, FACP
This webinar will educate primary care physicians on screening tools for assessment of axial spondyloarthritis, including referral strategies presented by the Assessment of SpondyloArthritis international Society (ASAS) and the Prevalence of Axial Spondyloarthritis (PROSpA) to help inform decisions on appropriate referrals to rheumatologists. This is the fifth chapter of a series of videos exploring early recognition of axSpA.
Join us for a live webinar with Dr. Danve and Dr. Magrey on May 15.
Upon completion of this session, participants should be able to:
- Recognize the importance of screening for inflammatory back pain and other spondyloarthritis features
- Use appropriate screening tools in the early assessment of axial spondyloarthritis (axSpA)
- Outline referral strategies to rheumatologists for further evaluation upon suspicion of axSpA
This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.
Marina N. Magrey, MD
Case Western Reserve University School of Medicine, MetroHealth Medical Center
Abhijeet S. Danve, MBBS, MD, FACP
Rheumatologist, Assistant Professor of Medicine, Director, Yale Spondyloarthritis Program, Yale School of Medicine
Sponsored by Novartis Pharmaceuticals Corporation
11:15am–12:45pm ET CME/CE Accredited Session
Curbside Cardiology Consult: Peripheral Artery Disease and Heart Failure
Ty J. Gluckman, MD, FACC, FAHA | Alison L. Bailey, MD, FACC, FAACVPR
Peripheral artery disease affects nearly 9 million Americans and is associated with significantly increased risk of cardiovascular morbidity and mortality. Beyond initiation of therapies to reduce cardiovascular risk, many interventions used to treat peripheral artery disease aim to improve functional status and quality of life. Join us for this overview, where we'll review the epidemiology, classification, evaluation and treatment of this condition.
Heart failure is a global pandemic that continues to increase in prevalence. Despite the availability of established and novel therapies, mortality and morbidity in heart failure remains high. Join us for this overview of heart failure classification and pathophysiology, the evidence base supporting various treatments, and current guideline recommendations.
Ty J. Gluckman, MD, FACC, FAHA
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS),, Providence Heart Institute, Providence St. Joseph Health, Portland, OR
Alison L. Bailey, MD, FACC, FAACVPR
Governor, Tennessee Chapter,, American College of Cardiology, Washington, DC
12:55–1:40pm ET CME/CE Accredited Session
Top COVID-19 Questions: Mental Health and Gastroenterology
Shirah Vollmer, MD | Neilanjan Nandi, MD, FACP
The COVID-19 pandemic has taken its toll not only on patients’ lungs but on their gastrointestinal systems and mental health as well. Drs. Shirah Vollmer and Neilanjan Nandi share practical answers to the top questions they frequently hear from other clinicians on COVID-19−related GI and anxiety disorders. Chances are, you have some of the same questions! Get the answers you need to steer your patients through this difficult time.
Shirah Vollmer, MD
Clinical Professor of Psychiatry, David Geffen School of Medicine at UCLA, Los Angeles, CA
Neilanjan Nandi, MD, FACP
Associate Professor of Clinical Medicine, Inflammatory Bowel Diseases Center, University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia, PA
1:50–2:35pm ET Non-CME Industry Theater
Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?
Daniel Katselnik, MD
Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information.
Daniel Katselnik, MD
Endocrinologist, Diabetes and Metabolism Specialists, Shavano Park, Texas
Sponsored by Novo Nordisk Inc.
2:45–4:15pm ET CME/CE Accredited Session
Nutritional and Pharmacological Approach to IBS-D and its Masqueraders
William D. Chey, MD, FACG, AGAF, FACP, RFF | Kate Scarlata, MPH, RDN | Neilanjan Nandi, MD, FACP
Identifying patients with irritable bowel syndrome (IBS) can be challenging since many other illnesses masquerade as IBS. This session will provide an overview of practical diagnostic and treatment considerations for managing patients with IBS-D in the primary care setting. Diagnostic approaches for IBS-D will be reviewed in the context of conditions that commonly mimic symptoms of the disorder. Participants will learn about the latest evidence-based treatment strategies for IBS-D, including nutritional approaches, behavioral therapies, and conventional and newer pharmacologic therapies.
William D. Chey, MD, FACG, AGAF, FACP, RFF
Nostrant Collegiate Professor of GI, Professor of Nutrition Sciences, Director, GI Physiology Laboratory, Director, Nutrition & Behavioral Medicine Program, Medical Director, Michigan Bowel Control Program, Michigan Medicine, Ann Arbor, MI
Kate Scarlata, MPH, RDN
For a Digestive Peace of Mind, Medway, MA
Neilanjan Nandi, MD, FACP
Associate Professor of Clinical Medicine, Inflammatory Bowel Diseases Center, University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia, PA
4:25–5:10pm ET Non-CME Industry Theater
The Continuum of Heart Failure
Pam R. Taub, MD, FACC
The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF.
Pam R. Taub, MD, FACC
Associate Professor of Medicine, UC San Diego Health System, San Diego, California
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC
4:25–5:10pm ET Non-CME Industry Theater
Addressing Pneumococcal Disease in Adults 65 and Older: 2019 CDC Recommendations
Paul E. Schulz, MD
- Examine the data on the burden of pneumococcal disease in adults aged 65 years and older
- Discuss 2019 CDC Recommendations
- Review CDC recommendations using case studies
Paul E. Schulz, MD
Dr. Paul S. Schulz is currently the System Epidemiologist and Medical Director of Infection Prevention, Employee Health, and Anti-Microbial Stewardship for Norton Healthcare in Louisville, Kentucky. Dr. Schulz received a Bachelor of Science in Chemical Engineering from the University of Cincinnati and attended Medical School at the University of Louisville School of Medicine. After graduation, Dr. Schulz completed a residency in Internal Medicine and a fellowship in Infectious Diseases also at the University of Louisville. Dr. Schulz is board certified in Internal Medicine and Infectious Disease and continues to provide clinical services in Infectious Diseases.
Sponsored by Merck